Literature DB >> 16242650

Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.

Ricardo J Giordano1, Cristiane D Anobom, Marina Cardó-Vila, Jorge Kalil, Ana P Valente, Renata Pasqualini, Fabio C L Almeida, Wadih Arap.   

Abstract

Vascular endothelial growth factor (VEGF) is central to the survival and development of the vascular and nervous systems. We screened phage display libraries and built a peptide-based ligand-receptor map of binding sites within the VEGF family. We then validated a cyclic peptide, CPQPRPLC, as a VEGF-mimic that binds specifically to neuropilin-1 and VEGF receptor-1. Here, we use NMR spectroscopy to understand the structural basis of the interaction between our mimic peptide and the VEGF receptors. We show that: (1) CPQPRPLC has multiple interactive conformations; (2) receptor binding is mediated by the motif Arg-Pro-Leu; and (3) the Pro residue within Arg-Pro-Leu participates in binding to neuropilin-1 but not to VEGF receptor-1, perhaps representing an evolutionary gain-of-function. Therefore, Arg-Pro-Leu is a differential ligand motif to VEGF receptors and a candidate peptidomimetic lead for VEGF pathway modulation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242650     DOI: 10.1016/j.chembiol.2005.07.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  15 in total

Review 1.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

2.  The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease.

Authors:  Richard L Sidman; Jianxue Li; Matthew Lawrence; Wenzheng Hu; Gary F Musso; Ricardo J Giordano; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap
Journal:  Sci Transl Med       Date:  2015-10-14       Impact factor: 17.956

3.  Structural basis for ligand and heparin binding to neuropilin B domains.

Authors:  Craig W Vander Kooi; Manuel A Jusino; Benjamin Perman; David B Neau; Henry D Bellamy; Daniel J Leahy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

Review 4.  Peptide aptamers: development and applications.

Authors:  Sergey Reverdatto; David S Burz; Alexander Shekhtman
Journal:  Curr Top Med Chem       Date:  2015       Impact factor: 3.295

5.  From combinatorial peptide selection to drug prototype (I): targeting the vascular endothelial growth factor receptor pathway.

Authors:  Ricardo J Giordano; Marina Cardó-Vila; Ahmad Salameh; Cristiane D Anobom; Benjamin D Zeitlin; David H Hawke; Ana P Valente; Fábio C L Almeida; Jacques E Nör; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-26       Impact factor: 11.205

6.  Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.

Authors:  Esther Grueso; Cristina Sánchez-Martínez; Tania Calvo-López; Fernando J de Miguel; Noelia Blanco-Menéndez; Marian Fernandez-Estevez; Maria Elizalde; Jorge Sanchez; Omar Kourani; Diana Martin; Aroa Tato; Milagros Guerra; Germán Andrés; José M Almendral
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

7.  Targeting neuropilin-1 in human leukemia and lymphoma.

Authors:  Katja Karjalainen; Diana E Jaalouk; Carlos E Bueso-Ramos; Amado J Zurita; Akihiko Kuniyasu; Bedrich L Eckhardt; Frank C Marini; Benjamin Lichtiger; Susan O'Brien; Hagop M Kantarjian; Jorge E Cortes; Erkki Koivunen; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

Review 8.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

9.  In vivo tumor cell targeting with "click" nanoparticles.

Authors:  Geoffrey von Maltzahn; Yin Ren; Ji-Ho Park; Dal-Hee Min; Venkata Ramana Kotamraju; Jayanthi Jayakumar; Valentina Fogal; Michael J Sailor; Erkki Ruoslahti; Sangeeta N Bhatia
Journal:  Bioconjug Chem       Date:  2008-07-09       Impact factor: 4.774

Review 10.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.